GENETIC SEQUENCES CONFERRING DISEASE RESISTANCE IN PLANTS AND USES THEREFOR

Abstract: The present invention relates generally to genetic sequences, and more particularly to genetic sequences which confer or otherwise facilitate disease resistance in plants such as against rust and mildew. The present invention further provides for transgenic plants carrying the subject genetic sequences enabling the generation of disease resistant plants. The present invention is particularly useful for developing disease resistance in crop varieties.

Description: GENETIC SEQUENCES CONFERRING DISEASE RESISTANCE IN PLANTS AND USES THEREFOR The present invention relates generally to genetic sequences, and more particularly to genetic sequences which confer or otherwise facilitate disease resistance in plants such as against rust and mildew. The present invention further provides for transgenic plants carrying the subject genetic sequences enabling the generation of disease resistant plants. The present invention is particularly useful for developing disease resistance in crop varieties. Bibliographic details of the publications numerically referred to in this specification are collected at the end of the description. Sequence Identity Numbers (SEQ ID NOs.) for the nucleotide and amino acid sequences referred to in the specification are defined following the bibliography. Throughout this specification, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated element or integer or group of elements or integers but not the exclusion of any other element or integer or group of elements or integers. The rapidly increasing sophistication of recombinant DNA technology is greatly facilitating the efficacy of commercially important agricultural processes. Of particular concern is the effect of plant diseases on the efficacy of these agricultural processes. Plant diseases and particularly diseases in crop plants represent a major contributing factor in crop losses capable of causing economically significant down turn in productivity per square metre. The development, therefore, of disease resistant plants is an important goal in agricultural and horticultural research. Major genes conditioning resistance to plant diseases have been investigated extensively in agriculture. Of particular economic importance are genes controlling resistance to rust and mildew. Rust is an especially significant problem amongst broad acre crops such as wheat, barley and cereal grains and is caused by infection with a class of fungi known as the Basidiomycetes. Although rust resistance genes are a potentially invaluable genetic resource in agriculture, the molecular basis of major gene resistance is unknown and, until the present invention, genes conferring rust or mildew resistance had not been cloned. Genetic analysis indicates that rust resistance genes control specific recognition of the products of rust avirulence genes. In developing disease resistance varieties using disease resistance genes, plant breeders deploy resistance genes that match the avirulence genes present in the local strains of the pathogens. The pathogen populations are dynamic and frequently new pathogenic strains arise by any number of means such as by mutation, recombination or accidental or natural introduction of new pathogenic strains. The existing disease resistant varieties then become susceptible to the new pathogenic strains. Plant breeders are then forced to develop new disease resistant varieties. At present, breeders use resistance genes that exist in either wheat or its relatives as their pool of new genes. The cloning of a resistance gene is the first step in understanding the basis of resistance gene action and in particular the specificity control mechanism. Ellis et al (1) have described the development of a transposon tagging system to isolate rust resistance genes from flax (linseed, Linum usitatissimum). However, despite the general effectiveness of the methodology, the isolation of mutant flax plants possessing a tagged resistance gene has not been a straight forward procedure (2). In accordance with the present invention, genetic sequences conferring rust resistance have been cloned from flax. The cloning of these sequences provides the means of generating transgenic plants with de novo, increased or otherwise enhanced rust resistance. The present invention also permits the screening through genetic or immunological means similar rust resistance genes in other plants for use in developing or enhancing rust resistance in commercially and economically important species. Furthermore, the application of knowledge of the molecular basis behind resistance gene action and the specificity thereof offers the potential of a new source of genes produced by a variety of recombinant techniques. These new genes with altered disease resistance specificites are referred to herein as "modular resistance genes". Accordingly, one aspect of the present invention comprises an isolated nucleic acid molecule comprising a sequence of nucleotides which confers or otherwise facilitates disease resistance in a plant. More particularly, the disease resistance is rust resistance. The present invention extends, however, to resistance to obligate biotrophic pathogens including but not limited to fungi, viruses and nematodes. Another aspect of the present invention is directed to a nucleic acid molecule which comprises a sequence of nucleotides corresponding or complementary to the nucleotide sequence set forth in F ure 1 (SEQ ID NO:l) or having at least 45% similarity to all or part thereof and wherein said nucleic acid molecule confers or otherwise facilitates rust resistance in a plant. In a related aspect of the present invention there is provided a nucleic acid molecule which comprises a sequence of nucleotides encoding or complementary to a sequence of nucleotides encoding the amino acid sequence set forth in Figure 1 (SEQ ID NOs:2 to 5) or having at least 45% similarity to all or part thereof and wherein said nucleic acid molecule confers or otherwise facilitates rust resistance in a plant Preferably, the percentage similarity to the sequence set forth in SEQ ID NO:l or SEQ ID NOs:2 to 5 is at least 50%. Even more preferably, the percentage similarity is at least 60%. Still more preferably, the percentage similarity is at least 65%. Yet still more preferably, the percentage similarity is at least 80-90% includmg at least 91% or 93% or 95%. For the purposes of nomenclature, the sequences in Figure 1 relate to the "L6" allele of the disease resistance gene L which controls host resistance to flax rust races that carry the corresponding avirulence gene AL6. However, the present invention extends to other alleles of the gene or alleles of the M gene. Accordingly, a related embodiment of the present invention contemplates a nucleic acid molecule comprising a sequence of nucleotides encoding or complementary to a sequence encoding a peptide, polypeptide or protein wherein said peptide, polypeptide or protein is capable of interacting with an avirulence gene product on a flax rust. Generally, when the rust resistance gene is the L6 allele, the corresponding avirulence gene is AL6. A similar nomenclature applied to the other alleles of the L gene, for example, the L2 and L10 alleles. Their corresponding avirulence genes are AL2 and AL10, respectively. A further aspect of the present invention contemplates a nucleic acid molecule which confers or otherwise facilitates rust resistance in a plant and which is capable of hybridising under at least low stringency conditions to the nucleic acid molecule defined in SEQ ID NO: 1. For the purposes of defining the level of stringency, reference can conveniently be made to Sambrook et al (3), which is herein incorporated by reference, where the washing steps at pages 9.52-9.57 are considered high stringency. A "low" stringency is defined herein as being in 0.1-0.5% w/v SDS at 37-45°C for 2-3 hours. Depending on the source and concentration of nucleic acid involved in the hybridisation, alternative conditions of stringency may be employed such as "medium" stringent conditions which are considered herein to be 0.25-0.5% w/v SDS at >45°C for 2-3 hours or "high" stringent conditions as disclosed by Sambrook et al (3). Although not intending to limit the present invention to any one theory or mode of action, it is proposed that the genetic sequences of the present invention are necessary for specific recognition of the products of rust avirulence genes. Accordingly, the genetic sequences are useful in enhancing existing rust resistance genes, providing de novo the required specific recognition of rust avirulence gene products or being introduced together with rust avirulence genes on, for example, a single genetic cassette. Accordingly, these aspects of the invention are covered by the expression "conferring or otherwise enhancing rust resistance" or other similar expression. The present invention is particularly directed to resistance conferring or facilitating genetic sequences from flax plants and from its relative Linum marginale. However, the subject invention clearly contemplates other sources of rust resistance genes such as but not limited to other species of Linu , soybeans, sunflowers and cereals amongst other plants including wild varieties of wheat, barley and maize. The genetic sequences conferring or otherwise facilitating rust resistance may correspond to the naturally occurring sequence or may differ by one or more nucleotide substitutions, deletions and or additions. Accordingly, the present invention extends to rust resistance genes and any functional alleles mutants, derivatives, parts, fragments, homologues or analogues thereof or non-functional molecules but which are at least useful as, for example, genetic probes or in the generation of immunologically interactive recombinant molecules. The present invention further extends to the promoter region from the rust resistance genes such as from L6, L2 or L10. A preferred promoter is from L6. Such promoters may be useful in driving expression of transgenes. Examples of alleles of the flax rust resistance gene L include, but are not limited to L6, L2 and L10 although all alleles of the L locus are encompassed by the present invention. The present invention also extends to alleles of the M locus. The present invention further contemplates recombinant or synthetic rust resistance gene products, such as the products of the L6, L2 or L10 alleles of the L resistance gene. A particularly preferred recombinant or synthetic rust resistance gene product is from the L6 gene. The L6 protein has the following features; an amino terminal half containing a nucleotide binding site (NBS) consisting of several motifs including the P-loop and further downstream, a kinase-2 motif (14). In L6, the kinase-2 sequence is ILVVLDDVD (SEQ ID NO: 13) and more generally, XXXXDDX where X=L,I,V,F (using single amino acid nomenclature defined below). The C-terminal half of the polypeptide is a leucine rich region consisting of approximately 17% leucine residues. Within this region, stretches of residues appear where leucine is reiterated LXXL or LXL where X = any residue. These sequences are similar to the leucine-rich repeat sequences of 25-30 residues that are found in many proteins that form protein-protein interactions. More particularly in the L6 product, the leucine rich region of L6 consists of two parts with the C-terminal part of the region consisting of two direct leucine rich repeats of 146 and 149 amino acids that are 74% identical. The above mentioned functional mutants, derivatives, parts, fragments, homologues and analogues of are referred to herein as "rust resistance-like genes" or "rust resistance genetic sequences". Reference herein to "genes" is to be taken in its broadest context and includes a classical genomic gene as well as mRNA or cDNA corresponding to the coding regions (i.e. exons) of the gene. The term "gene" is also used to describe synthetic or fusion molecules encoding all or part of a functional product. Preferred rust resistance-like genes are derived from a naturally occurring rust resistance gene by standard recombinant techniques. Generally, a rust resistance gene may be subjected to mutagenesis to produce single or multiple nucleotide substitutions, deletions and or additions. Nucleotide insertional derivatives of the rust resistance gene of the present invention include 5' and 3' terminal fusions as well as intra-sequence insertions of single or multiple nucleotides. Insertional nucleotide sequence variants are those in which one or more nucleotides are introduced into a predetermined site in the nucleotide sequence although random insertion is also possible with suitable screening of the resulting product. Deletional variants are characterised by the removal of one or more nucleotides from the sequence. Substitutional nucleotide variants are those in which at least one nucleotide in the sequence has been removed and a different nucleotide inserted in its place. Such a substitution may be "silent" in that the substitution does not change the amino acid defined by the codon. Alternatively, substituents are designed to alter one amino acid for another similar acting amino acid. Typical substitutions are those made in accordance with the following: Suitable residues for amino acid substitutions Orieinal Residue Exemplarv Substitutions Ala Ser Arg Lys Asn Gin; His Asp Glu Cys Ser Gin Asn Glu Asp Gly Ala His Asn; Gin He Leu; Val Leu He; Val Lys Arg; Gin; Glu Met Leu; He Phe Met; Leu; Tyr Ser Thr Thr Ser Trp Tyr Tyr Trp; Phe Val He; Leu In a particularly preferred embodiment, the rust resistance genetic sequences or like genetic sequences are employed to identify and isolate similar genes from other plants. According to this embodiment, there is contemplated a method for identifying a rust resistance genetic sequence or rust resistance-like genetic sequence in a plant, said method comprising contacting genomic DNA or cDNA isolated from said plant with a hybridisation effective amount of a genetic sequence conferring or otherwise rust resistance or part thereof and then detecting said hybridisation. Preferably, the latter mentioned genetic sequence is from flax or similar plant such as a Linum species. In a most preferred embodiment, the latter genetic sequence is as set forth in SEQ ID NO:l or corresponds to a probe such as defined in Figure 2 (SEQ ID NO:l l). Preferably, the latter genetic sequence is labelled with a reporter molecule capable of giving an identifiable signal (e.g. a radioisotope such as P or S or a biotintylated molecule). Preferably, the plant to be screened is a flax, a Linum species or a grain crop plant such as wheat, barley, maize, rye, lupins or rice and/or wild varieties of same. Alternatively, the plant is screened using antibodies to a recombinant product of a rust resistance gene. According to a first aspect of this embodiment, the present invention provides for the expression of the subject genetic sequence in a suitable host (e.g. a prokaryote or eukaryote) to produce full length or non-full length recombinant rust resistance gene products. The only requirement being that the recombinant products are immunologically interactive with antibodies to all or part of a rust resistance gene product. The immunological screening for rust resistance gene products may, in some circumstances, be more suitable than a genetic screening procedure. Another aspect of the present invention is, therefore, directed to antibodies to a recombinant rust resistance gene product or part or fragment thereof. Such antibodies may be monoclonal or polyclonal and may be selected from naturally occurring antibodies to a rust resistance gene product or may be specifically raised to a recombinant rust resistance gene product. In the case of the latter, the rust resistance gene product may first need to be associated with a carrier molecule. Alternatively, fragments of antibodies may be used such as Fab fragments. Furthermore, the present invention extends to recombinant and synthetic antibodies and to antibody hybrids. A "synthetic antibody" is considered herein to include fragments and hybrids of antibodies. In additions, antibodies may be raised to fragments or derivatives of the rust resistance gene product such as oligopeptides derived from or based on the product of, for example, the L6 gene. The antibodies and/or the recombinant rust resistance gene products of the present invention are particularly useful for the immunological screening of rust resistance gene products in various plants, in monitoring expression of rust resistance genetic sequences in transgenic plants and as a proprietary tagging system. In one embodiment, specific antibodies are used to screen for rust resistance gene products in plants. Techniques for the assays contemplated herein are known in the art and include, for example, sandwich assays and ELISA. It is within the scope of this invention to include any second antibodies (monoclonal, polyclonal or fragments of antibodies) directed to the first mentioned antibodies discussed above. Both the first and second antibodies may be used in detection assays or a first antibody may be used with a commercially available anti- immunoglobulin antibody. An antibody as contemplated herein includes any antibody specific to any region of a recombinant rust resistance gene product. Both polyclonal and monoclonal antibodies are obtainable by immunisation with a recombinant rust resistance gene product and either type is utilisable for immunoassays. The methods of obtaining both types of sera are well known in the art. Polyclonal sera are less preferred but are relatively easily prepared by injection of a suitable laboratory animal with an effective amount of recombinant rust resistance gene product, or antigenic or immunointeractive parts thereof, collecting serum from the animal and isolating specific sera by any of the known immunoadsorbent techniques. Although antibodies produced by this method are utilisable in virtually any type of immunoassay, they are generally less favoured because of the potential heterogeneity of the product. The use of monoclonal antibodies in an immunoassay is particularly preferred because of the ability to produce them in large quantities and the homogeneity of the product. The preparation of hybridoma cell lines for monoclonal antibody production derived by fusing an immortal cell line and lymphocytes sensitised against the immunogenic preparation can be done by techniques which are well known to those who are skilled in the art (see, for example, references 4, 5 and 6). The presence of a rust resistance gene product in a plant or more commonly plant extract may be accomplished in a number of ways such as by Western blotting and ELISA procedures. A wide range of immunoassay techniques are available as can be seen by reference to US Patent Nos. 4,016,043, 4, 424,279 and 4,018,653. These, of course, includes both single-site and two-site or "sandwich" assays of the non- competitive types, as well as in the traditional competitive binding assays. These assays also include direct binding of a labelled antibody to a target. Sandwich assays are among the most useful and commonly used assays and are favoured for use in the present invention. A number of variations of the sandwich assay technique exist, and all are intended to be encompassed by the present invention. Briefly, in a typical forward assay, an unlabelled antibody is immobilised on a solid substrate and the sample to be tested brought into contact with the bound molecule. After a suitable period of incubation, for a period of time sufficient to allow formation of an antibody-antigen complex, a second antibody specific to the antigen, labelled with a reporter molecule capable of producing a detectable signal is then added and incubated, allowing time sufficient for the formation of another complex of antibody-antigen-labelled antibody. Any unreacted material is washed away, and the presence of the antigen is determined by observation of a signal produced by the reporter molecule. In this case, the first antibody is raised to a recombinant rust resistance gene product and the antigen is a rust resistance gene product in a plant. The results may either be qualitative, by simple observation of the visible signal, or may be quantitated by comparing with a control sample containing known amounts of hapten. Variations on the forward assay include a simultaneous assay, in which both sample and labelled antibody are added simultaneously to the bound antibody. These techniques are well known to those skilled in the art, including any minor variations as will be readily apparent. In accordance with the present invention the sample is one which might contain rust resistance gene product and include crude or purified plant extract such as extracts of leaves, roots and stems. In the typical forward sandwich assay, a first antibody raised against a recombinant rust resistance gene product is either covalently or passively bound to a solid surface. The solid surface is typically glass or a polymer, the most commonly used polymers being cellulose, polyacrylamide, nylon, polystyrene, polyvinyl chloride or polypropylene. The solid supports may be in the form of tubes, beads, discs of microplates, or any other surface suitable for conducting an immunoassay. The binding processes are well-known in the art and generally consist of cross-linking, covalent binding or physically adsorption, the polymer-antibody complex is washed in preparation for the test sample. An aliquot of the sample to be tested is then added to the solid phase complex and incubated for a period of time sufficient (e.g. 2-40 minutes) and under suitable conditions (e.g. 25°C) to allow binding of any antigen present in the sample to the antibody. Following the incubation period, the reaction locus is washed and dried and incubated with a second antibody specific for a portion of the first antibody. The second antibody is linked to a reporter molecule which is used to indicate the binding of the second antibody to the hapten. An alternative method involves immobilising the target molecules in the biological sample and then exposing the immobilised target to specific antibody which may or may not be labelled with a reporter molecule. Depending on the amount of target and the strength of the reporter molecule signal, a bound target may be detected by direct labelling with the antibody. Alternatively, a second labelled antibody, specific to the first antibody is exposed to the target-first antibody complex to form a target- first antibody-second antibody tertiary complex. The complex is detected by the signal emitted by the reporter molecule. By "reporter molecule" as used in the present specification, is meant a molecule which, by its chemical nature, provides an analytically identifiable signal which allows the detection of antigen-bound antibody. Detection may be either qualitative or quantitative. The most commonly used reporter molecules in this type of assay are either enzymes, fluorophores or radionuclide containing molecules (i.e. radioisotopes) and chemiluminescent molecules. In the case of an enzyme immunoassay, an enzyme is conjugated to the second antibody, generally by means of glutaraldehyde or periodate. As will be readily recognised, however, a wide variety of different conjugation techniques exist, which are readily available to the skilled artisan. Commonly used enzymes include horseradish peroxidase, glucose oxidase, beta-galactosidase and alkaline phosphatase, amongst others. The substrates to be used with the specific enzymes are generally chosen for the production, upon hydrolysis by the corresponding enzyme, of a detectable colour change. Examples of suitable enzymes include alkaline phosphatase and peroxidase. It is also possible to employ fluorogenic substrates which yield a fluorescent product rather than the chromogenic substrates noted above. In all cases, the enzyme-labelled antibody is added to the first antibody-hapten complex, allowed to bind, and then the excess reagent is washed away. A solution containing the appropriate substrate is then added to the complex of antibody-antigen-antibody. The substrate will react with the enzyme linked to the second antibody, giving a qualitative visual signal, which may be further quantitated, usually spectrophotometrically, to give an indication of the amount of hapten which was present in the sample. The term "reporter molecule" also extends to use of cell agglutination or inhibition of agglutination such as red blood cells on latex beads, and the like. Alternately, fluorescent compounds, such as fluorescein and rhodamine, may be chemically coupled to antibodies without altering their binding capacity. When activated by illumination with light of a particular wavelength, the fluorochrome- labelled antibody adsorbs the light energy, inducing a state to excitability in the molecule, followed by emission of the light at a characteristic colour visually detectable with a light microscope. As in enzyme immunoassays (EIA), the fluorescent labelled antibody is allowed to bind to the first antibody-hapten complex. After washing off the unbound reagent, the remaining tertiary complex is then exposed to the light of the appropriate wavelength the fluorescence observed indicates the presence of the hapten of interest. Immunofluorescene and EIA techniques are both very well established in the art and are particularly preferred for the present method. However, other reporter molecules, such as radioisotope, chemiluminescent or bioluminescent molecules, may also be employed. It will be readily apparent to the skilled technician how to vary the above assays and all such variations are encompassed by the present invention. The present invention is particularly described with reference to the flax rust resistance gene L and its alleles L6, L2 and L10. This is done, however, with the understanding that the subject invention extends to a range of resistance genes and alleles thereof for rust and other pathogens. In fact, the present invention extends to a resistance gene characterised by said gene encoding a product having at least one leucine rich region. Preferably, the leucine rich region is a leucine rich repeat at the 3' end of the molecule and has at least 60% similarly to each other more preferably at least 70% similarity and even more preferably at least 80% similarity. Still more preferably, the leucine rich region corresponds to the following amino acid sequence: PDLIELLPCELGGQTW . VPSMAELTIRDCPRLEVGPMIRSLPKFPMLKK LDLAVANITKEEDLDAIGSLEELVSLELELDDTSSGIERIVSSSKLQKLT TLWKVPSLREIEGLEELKSLQD YLEGCTSLGRL PLEKLKE LDIGGC (SEQ ID NO : 12 ) or having at least 60% similarly thereto or more preferably at least 70% similarity or even more preferably at least 80% similarity thereto. Alternatively or in addition to, the rust resistance gene further encodes a p-Loop at its 5' end encoding the amino acid sequence: GXXXXGKT/S (SEQ ID NO:8), where X is any amino acid residue. More preferably, the p-Loop sequence comprises the amino acid residues: GMGGIGKTT (SEQ ID NO:9), and more particularly GLYGMGGIGKTT (SEQ ID NO: 10), or having one or more amino acid substitutions, insertions and/or deletions thereto provided that such derivatives still function as a p-Loop. A p-Loop is involved in ATP/GTP binding. It is proposed herein that copy number and amino acid sequence of this repeated element are the determinants of the gene-for-gene specificity of rust resistance genes. Mixing and matching of these elements from existing genes will provide a potential means for creating new and useful resistance gene specificities for use in plant breeding. Such new genes are referred to herein as "modular resistance genes". This is a completely novel approach to disease resistance breeding. According to this embodiment, there is contemplated a modular resistance gene characterised in that said gene encodes a non-naturally occurring leucine rich region. By "non-naturally occurring" is meant to include the manipulation of a genetic sequence to introduce a leucine rich encoding sequence, to increase the copy number of an existing leucine rich encoding sequence, to delete or insert a nucleotide sequence for or into a leucine rich encoding sequence or to otherwise modify a leucine rich encoding sequence to modulate pathogen specificity of a disease resistance gene. For example, the leucine rich regions of two or more of alleles of the L locus such as L6, L2 and L10 could be combined to broaden the range of pathogens to which a gene can confer resistance. Alternatively, combinations of allels from the L and M loci could be made. The present invention contemplates, therefore, a method of producing a modular resistance gene conferring resistance to a pathogen in a plant by manipulating the leucine rich regions in a disease resistance gene. The present invention further extends to transgenic plants such as transgenic crop plants (e.g. wheat, barley or maize) carrying a non-indigenous genetic sequence conferring or otherwise facilitating rust resistance in said plant. Preferably, the non- indigenous genetic sequence is from a closely related species to the transgenic plant. The expression of the non-indigenous genetic sequence may be constitutive or inducible or developmentally regulated. Furthermore, the non-indigenous sequence may be inserted into or fused to a particular endogenous genetic sequence. In a most preferred embodiment, the transgenic plant is wheat and the non-indigenous genetic sequence is from a wild variety of wheat, barley, maize, flax or Linum species. Other transformed species or resistance gene sources are not excluded. The present invention is further described by reference to the following non-limiting Figures and Examples. In the Figures: Figure 1 is a representation of the nucleotide sequence (SEQ ID NO:l) and corresponding amino acid sequence (SEQ ID NOs:2 to 5) of the rust resistance gene L6. There are two predicted products, the "full length" and "truncated" products. The truncated product results from an alternately spliced mRNA that retains intron 3. In the absence of the splicing of this intron, translation would continue through the 82bp intron 3 as a consequence of not changing frames, a stop codon is reached just downstream of the end of the intron. This results in a product from which the major portion of the leucine rich region is removed and also the addition of an extra 29 amino (see underlined amino acids [SEQ ID NOs: 6 and 7) that are not in the full length product. Figure 2 is a representation of part of the L6 gene showing the LU-1 probe (underlined) and Ac insertion in mutant X75 (SEQ ID NO:l 1). Figure 3 is a schematic representation of the L6 gene showing location of LU-2 probe. Figure 4 is a representation of the amino acid sequences of the leucine rich repeat in L6. Figure 5 is a schematic representation of the L locus alleles. EXAMPLE 1 PLANT MATERIAL Experiments were conducted in the line of flax called "Forge" which is homozygous for the rust resistance genes L 6 , M, N and P 2 (2). One particular flax is designated TC257 and is a primary transformant of "Forge" possessing 10 copies of the maize transposable element Ac (1). Rust gene cultivars are referred to as "Birio" (L 6 ), "Dakota" (M), "Bombay" (N) and "Abyssinian" (P 2 ) (8). EXAMPLE 2 RUST STRAINS Four rust strains were used to screen for mutants. Three of these strains, designated CH5-78, CH5-84 and CH5-133, were obtained by selfing strain CH5. The fourth strain designated C was a parent strain of CH5. The origins of C and CH5 have been previously described (7). Each of these strains is avirulent on one of the single gene differentials and virulent on the other three. Strain CH5-84 is avirulent on "Birio" (L 6 ), CH5-78 is avirulent on "Dakota" (M), C is avirulent on "Bombay" (N) and CH5-133 is avirulent on "Abyssinian" (P ). Rust maintenance and inoculation procedures were as previously described (8). EXAMPLE 3 TRANSFORMATION Flax cotyledons were transformed with either the vector pKU3 (9), pBT175 (10), pB135SAcl l, 12 (11) or an Ac element in which the OCS enhancer (12) had been inserted at the BamHl site at position 182, according to the protocol previously described (13). EXAMPLE 4 TAGGING SCHEME The tagging scheme used in this study has been described by Ellis et al (1) and Lawrence et al (13). "Forge" plants with and without Ac elements, including TC257 and its selfed progeny, were extensively crossed as the female parent with "Hoshangabad" to produce hybrid seed heterozygous for the four rust resistance genes. When seedlings were about 5 cm tall, the tip was cut off and the two lateral shoots that subsequently developed were inoculated with a mixture of the four rust strains, each of which recognise a single resistance gene. Most plants were resistant to all four rust strains. Susceptible mutants were of three types, namely, "whole", in which all leaves on both lateral shoots were susceptible, "bisectored", in which all leaves on one lateral were susceptible while the other shoot was entirely resistant and "mini-sectored", in which only some of the leaves on one shoot were susceptible. When rare rust-susceptible mutants were detected, the mutant gene was identified by recovering rust spores and inoculating these on to a set of four rust resistance genes L , M, N or P . If, for example, the rust recovered from a susceptible mutant plant grew on the M, N and P 2 differentials but not on the L 6 differential, then this indicated that the plant was mutant for the L 6 gene. EXAMPLE 5 DETECTION OF TRANSPOSED Ac ELEMENTS IN MUTANT PLANTS The procedure for identifying transposed Ac elements was as previously described (2). EXAMPLE 6 LAMBDA CLONING Flax DNA was digested with _9_.-7.HI or Bglϊl and the unfractionated DNA was cloned into the Lambda vector EMBL4 as previously described (3). EXAMPLE 7 GENETIC ANALYSIS Genetic analysis including RFLP techniques, PCR analysis, Southern blot analysis and linkage analysis were as previously described (1; 2). The nucleotide and corresponding amino acid sequence for the L6 gene is shown in Figure 1. There are two predicted products, the "full length" and "truncated" products. The truncated product results from an alternately spliced mRNA that retains intron 3. In the absence of the splicing of this intron, translation would continue through the 82bp intron 3 and as a consequence of not changing frames, a stop codon is reached just downstream of the end of the intron. This results in a product from which the major portion of the leucine rich region is removed and also the addition of an extra 29 amino acids (see underlined amino acids in Figure 1) that are not in the full length product. EXAMPLE 8 IDENTIFICATION AND CHARACTERISATION OF A RUST-SUSCEPTIBLE MUTANT PLANT IN WHICH THE L6 GENE HAS BEEN TAGGED BY Ac The TC257 (Example 1) line of transgenic flax containing at least 10 copies of Ac (1; 2), one of which was linked (29 map units) from the L6 rust resistance gene, was crossed extensively to a line without resistance genes and the progeny were screened for lack of L6 activity. One rust susceptible mutant lacking L6 specificity (designated mutant X75) contained a transposed Ac element which, from experimental evidence, is putatively located in the L6 gene. EXAMPLE 9 X75 CONTAINS A TRANSPOSED AC CLOSELY LINKED TO THE MUTANT L6 GENE The L6 mutant X75 contains a transposed Ac (referred to herein as "Tr-Ac") that is not present in its resistant parent. The location of this element was mapped with respect to the L6 gene. A joint segregation analysis of Tr-Ac and the mutant L6 gene demonstrated tight linkage of these two characters. X75 was crossed to cultivar "Birio" (L6) and progeny that inherited Tr-Ac were identified by Southern analysis. Two progeny plants, D766 and D769, were test-crossed to the cultivar "Hoshangabad" (no L6). Thirty six progeny were tested for L6 rust resistance and scored for the presence of Tr-Ac. Eighteen of the progeny were susceptible and these all possessed Tr-Ac while the remaining 18 were resistant and these all lacked Tr-Ac. This is the result expected if the allele for susceptibility is an L6 gene inactivated by Tr-Ac. The insertion site of Tr-Ac was also mapped by restriction fragment length polymorphism (RFLP) analysis in a family of 88 test-cross progeny in which L6 was segregating. A fragment of flax DNA (probe LU-1) isolated from a lambda clone containing the 3' junction between Tr-Ac and flax DNA, detected 3 RFLPs that distinguished the two parents when their DNA was cut with EcoRI, Bglll and Xbal. The analysis of the segregation of these three markers and the L6 gene in the test- cross demonstrated that all four markers were closely linked. A single recombinant individual involving L6 and the RFLP marker detected in Xbal digested DNA was detected among the 88 progeny. As detailed below, this recombination event present in progeny plant D237 occurred within the region of the L6 gene. EXAMPLE 10 RECOMBINATION IN THE VICINITY OF THE Ac INSERTION SITE ALTERS THE RESISTANCE REACTION OR SPECIFICITY OF L6 The RFLP probe LU-1 was used to establish a restriction map of the homologous regions of the resistant and susceptible parents of the test cross family and of the recombinant progeny plant D237. Three polymorphic restriction sites were detected and comparison of the maps demonstrated that a cross-over had occurred within a region of about 3kbp on either side of the Ac insertion site. The recombinant plant D237 was selfed and 16 progeny were screened with a rust isolate that recognises L6. The progeny and were also analysed by Southern blotting to detect the recombinant chromosome. The progeny segregated for rust reaction: 6 were fully susceptible while 10 were partially resistant with restricted rust growth confined to the younger leaves. This result is consistent with the segregation of a novel gene for partial resistance which was not present in the original Forge parent. There was a complete association between the second class with novel rust reaction and the presence of the recombinant chromosome. Thus, crossing over in the vicinity of the L6 gene results in an alteration of the L6 resistance phenotype. EXAMPLE 11 INDEPENDENT L6 MUTANTS CONTAIN INSERTIONS IN THE REGION OF 0.5 TO 3.0KB OF THE Ac INSERTION SITE Thirty four independent L6 mutants were isolated in the screen for tagged L6 genes. All but X75 were either deletions or, if not deletions, contained no transposed Ac elements (2). Analysis of mutants in the latter class using the LU-1 probe revealed thrt two of them (X3A and XI 17) contained a small (approximately 200bp) insertion in this region. In the case of XI 17, the mutant was compared to its resistant parent to confirm that the polymorphism was not pre-existing. In the case of X3 A, the insertion and loss of L6 had occurred somatically. Mutant X3A arose as a sector. Among two shoots on a single Fl plant, one (X3A) had lost L6 and the second, X3B was wild-type for L6. DNA from the two sectors was examined using the LU-1 probe. An insertion was observed only in DNA from the mutant sector. EXAMPLE 12 EXCISION OF TR-AC IN PROGENY OF X75 IS ASSOCIATED WITH REVERSION TO RUST RESISTANCE The X75 mutant was selfed and progeny that were homozygous for the transposed Ac element were identified by Southern blotting. Selfed progeny of four such plants were in turn screened with a rust strain that recognises the L6 resistance specificity. Thirty seven resistant plants were identified among 3105 progeny. 15 of the revertants were examined by either PCR or Southern analysis for an excision fragment that would result from the excision of Ac from the L6 region. The excision marker occurred in all the plants. In two cases, the excision region was sequenced and small base changes, (an "Ac footprint") in the 8bp repeat that flanked Ac in X75 resulted from the excision process. EXAMPLE 13 A DNA PROBE ADJACENT TO Ac DETECTS A SECOND LOCUS IN FLAX. CLOSELY LINKED TO THE M RESISTANCE LOCUS A second DNA probe, LU-2 was isolated from the same lambda clone as LU-1. These two fragments are separated by about 2kb. LU-2, like many other flax DNA probes, hybridises to two genomic fragments in most restriction digests, providing molecular evidence for the tetraploid nature of flax. In Xbal digests, LU-2 detects two polymorphic markers, LU-2-1 and LU-2-2 that distinguish the resistant and susceptible parents of a test-cross family of 52 progeny among which the L6 and M resistance genes segregate. Joint segregation analysis of these two RFLP markers and the L6 and M resistance genes demonstrated complete linkage of LU-2-1 with L6 and LU-2-2 with the resistance gene M. Thus, cloning the L6 locus has allowed access to the M resistance gene region. The LU-2 probe and A flanked Ac in X75 in L6 is shown in Figures 2 and 3. EXAMPLE 14 RUST RESISTANCE GENES FORM A MULTIGENE FAMILY IN FLAX The probe LU-1 and several adjacent restriction fragments from a lambda clone were used as hybridisation probes to isolate a cDNA from a library generated using leaf mRNA. A cDNA clone and several other probes from the L6 gene have been used as probes for genomic Southern analysis. These probes generally detect multiple fragments in Southern blots which indicates that flax contains a family of genes of similar sequence. All RFLPs detected with this probe map to either the L6 or M resistance gene regions. EXAMPLE 15 PROBE LU-1 IDENTIFIES ALLELES OF L6 In genetic studies, the L locus of flax behaves as a single gene with multiple allelic specificities. Twelve resistance specificities map to the L locus. The probe LU-1 was used to examine a differential set of flax plants that each contain a single L allele (see Figures 2 and 3). DNA from the 12 differentials and from "Hoshangabad" which carries a "null" allele at the L locus was cut with Xbal, Bglϊl and EcoRI. In each case, a single fragment was detected in the L differentials and each L allele could be distinguished from the null allele of "Hoshangabad". Using these three enzymes, 10 RFLP genotypes were detected. Only two pairs of L alleles, L3 and L4 and L6 and L7, could not be distinguished with this limited sample of digests. EXAMPLE 16 A cDNA FROM FLAX DETECTS SEQUENCE SIMILARITY IN A WILD LINUM SPECIES Southern analysis of DNA from the wild species, Linum marginale which contains genes controlling resistance against flax rust, detected strongly hybridising fragments. EXAMPLE 17 DETERMINATION OF AMINO ACID SEQUENCE OF L6 The amino acid sequence of the L6 cDNA was determined and is shown in Figure 1. The amino acid sequence is shown in single letter code, single letter abbreviations for amino acids are defined below: Amino Acid One-letter Svmbol Alanine A Arginine R Asparagine N Aspartic acid D Cysteine C Glutamine Q 10 Glutamic acid E Glycine G Histidine H Isoleucine I Leucine L 15 Lysine K Methionine M Phenylalanine F Proline P Serine S 20 Threonine T Tryptophan w Tyrosine Y Valine V Amino Acid X EXAMPLE 18 COMPARISON OF AMINO ACID SEQUENCE OF LEUCINE RICH REPEAT FROM L6 The L6 allele comprises a leucine rich repeat at amino acid residues 969 to 1115 and 1116 to 1265. This repeat was compared for identity and the comparison is shown in Figure 4. Details of the comparisons are shown below: Length: 156 amino acids Gaps: 3 Gap weight: 3.000 Length weight: 0.100 Quality: 160.4 Ratio: 1.091 Average match: 0.540 Average mismatch: -0.396 Percent similarity: 82.979% Percent identity: 74.468 EXAMPLE 19 CLONING AND COMPARISON OF L LOCUS ALLELES Using the clones L6 gene as a probe (probe LU-1), the L2 and L10 alleles were cloned on EcoRl DNA fragments. These alleles have different resistance specificities and control resistance to flax rust strains that carry the AL2 and AL10 avirulence genes, respectively. The L2 and L10 clones were subject to restriction endonuclease analysis and a schematic represented is shown in Figure 5. The L2 EcoRI fragment is about 400bp longer than the corresponding L10 fragment. DNA sequence analysis of both ends of the L2 and L10 fragments revealed practically identical sequence (>90%) and indicates that L2 differs from L10 by about 400bp of extra DNA. Furthermore, sequence analysis and restriction fragment mapping from internal restriction sites confirmed the extra DNA and indicated that the 5' halves of L2, L6 and L10 are very similar (>90% identical) and that the differences between the alleles occurs in the 3' half of the gene. The difference in gene length occurs in a region coding for the leucine rich repeat structure of 156 amino acids that has two copies in L6 (Figure 4) and only one copy in a cDNA from a related but non-allelic gene called FC4. Those skilled in the art will appreciate that the invention described herein is susceptible to variations and modifications other than those specifically described. It is to be understood that the invention includes all such variations and modifications. The invention also includes all of the steps, features, compositions and compounds referred to or indicated in this specification, individually or collectively, and any and all combinations of any two or more of said steps or features. REFERENCES: 1. Ellis, J.G., Finnegan, E.J. and Lawrence, G.J. (1992) Theor. Appl. Genet. 85: 46-54. 2. Lawrence, G.J., Finnegan, E.J. and Ellis, J.G. (1993) The Plant J 4: 659- 669. 3. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning, A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 4. Douillard and Hoffman Basic Facts about Hybridomas, in Compendium of Immunology Vol II, ed. by Schwartz, 1981. 5. Kohler and Milstein Nature 256: 495-499, 1975. 6. Kohler and Milstein European Journal of Immunology 6: 511-519, 1976. 7. Lawrence, G.J., Mayo, G.M.E. and Shepherd, K.W. (1981) Phytopathology 71: 12-19. 8. Lawrence, G.J. (1988) Adv. Plant Pathol. 6: 313-3317 9. Baker, B., Coupland, G., Fedoroff, N., Starlinger, P. and Schell, J. (1987) EMBO J. 6: 1547-1554. 10. Taylor, B.H., Finnegan, E.J., Dennis, E.S. and Peacock, W.J. (1989) Plant Mol. Biol. 13: 109-118. 11. Finnegan, E.J., Lawrence, G.J., Dennis, E.S. and Ellis, J.G. (1993) Plant. Mol. Biol. in press. 12. Ellis, J.G., Llewellyn, D.J., Walker, J.C, Dennis, E.S. and Peacock, W.J. (1987) EMBO J. 6: 3203-3208. 13. Lawrence, G.J., Ellis, J.G., Finnegan, E.J., Dennis, E.S. and Peacock, W.J. (1989) Tagging rust resistance genes in flax. In Breeding Research: The Key to the Survival of the Earth (lyama, S. and Takeda, G, eds). Tsukuba: The Organising Committee, The 7th Int. Congr. of SABRAO, pp. 535-538. 14. Traut (1994) Eur. J. Biochem. 222: 9-12. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (ii) TITLE OF INVENTION: GENETIC SEQUENCES CONFERRING DISEASE RESISTANCE IN PLANTS AND USES THEREFOR (iii) NUMBER OF SEQUENCES: 13 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: DAVIES COLLISON CAVE (B) STREET: 1 LITTLE COLLINS STREET (C) CITY: MELBOURNE (D) STATE: VICTORIA (E) COUNTRY: AUSTRALIA (F) ZIP: 3000 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.25 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: PCT INTERNATIONAL (B) FILING DATE: 21 -APR- 1995 (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: PM5231/94 (AU) (B) FILING DATE: 21 -APR- 1994 (A) APPLICATION NUMBER: PM8103/94 (AU) (B) FILING DATE: 14-SEP-1994 (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: HUGHES DR, E JOHN L (C) REFERENCE/DOCKET NUMBER: EJHEK (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: +61 3 254 2777 (B) TELEFAX: +61 3 254 2770 (2) INFORMATION FOR SEQ ID Nθ:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4841 base pairs (B) TYPE*, nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 163..789 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1097..2203 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2669..4525 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2293..2586 (xi) SEQUENCE DESCRIPTION: SEQ ID Nθ:l: GAGCTCAGAA GTAAGGGATA AGGCAAGAAG CAGAGGAGCA GAGAGAAGAA CCAGCAAAGC 60 ACATGCAAAT TGAAGCAGGC AAGAACAGTT ACTGGAAATT CATTTATCTC TGCTTTCAAT 120 TTCTATCCTT CAGATCATTT CTGCTCAATT GAATCACTAG TC ATG AGT TAT TTG 174 Met Ser Tyr Leu 1 AGA GAA GTT GCT ACT GCT GTT GCC TTG CTT CTC CCT TTC ATT CTT CTC 222 Arg Glu Val Ala Thr Ala Val Ala Leu Leu Leu Pro Phe lie Leu Leu 5 10 15 20 AAC AAG TTT TGG AGA CCA AAT TCC AAA GAC TCA ATC GTC AAC GAT GAT 270 Asn Lys Phe Trp Arg Pro Asn Ser Lys Asp Ser He Val Asn Asp Asp 25 30 35 GAC GAT TCA ACA TCT GAA GTT GAT GCC ATA TCC GAC TCC ACA AAT CCC 318 Asp Asp Ser Thr Ser Glu Val Asp Ala He Ser Asp Ser Thr Asn Pro 40 45 50 TCT GGT TCA TTT CCC TCC GTG GAG TAT GAA GTG TTT TTG AGT TTC AGG 366 Ser Gly Ser Phe Pro Ser Val Glu Tyr Glu Val Phe Leu Ser Phe Arg 55 60 65 GGT CCA GAT ACT CGT GAA CAG TTC ACC GAT TTC CTA TAT CAG TCT CTC 414 Gly Pro Asp Thr Arg Glu Gin Phe Thr Asp Phe Leu Tyr Gin Ser Leu 70 75 80 CGT CGC TAT AAG ATT CAC ACT TTT AGG GAC GAC GAT GAG CTA CTC AAA 462 Arg Arg Tyr Lys He His Thr Phe Arg Asp Asp Asp Glu Leu Leu Lys 85 90 95 100 GGA AAA GAA ATA GGG CCC AAC CTC CTA CGA GCA ATT GAT CAG TCC AAA 510 Gly Lys Glu He Gly Pro Asn Leu Leu Arg Ala He Asp Gin Ser Lys 105 110 115 ATT TAC GTC CCG ATC ATA TCG AGC GGA TAT GCT GAT AGT AAG TGG TGT 558 He Tyr Val Pro He He Ser Ser Gly Tyr Ala Asp Ser Lys Trp Cys 120 125 130 CTT ATG GAG CTT GCT GAA ATT GTG AGA CGT CAA GAG GAG GAC CCT CGA 606 Leu Met Glu Leu Ala Glu He Val Arg Arg Gin Glu Glu Asp Pro Arg 135 140 145 CGC ATC ATA CTT CCT ATT TTT TAT ATG GTG GAT CCA AGT GAC GTA CGA 654 Arg He He Leu Pro He Phe Tyr Met Val Asp Pro Ser Asp Val Arg 150 155 160 CAT CAG ACT GGA TGT TAT AAA AAA GCA TTT CGA AAA CAC GCA AAT AAA 702 His Gin Thr Gly Cys Tyr Lys Lys Ala Phe Arg Lys His Ala Asn Lys 165 170 175 180 TTT GAT GGA CAG ACC ATA CAA AAC TGG AAA GAT GCT CTA AAG AAG GTC 750 Phe Asp Gly Gin Thr He Gin Asn Trp Lys Asp Ala Leu Lys Lys Val 185 190 195 GGA GAC TTA AAA GGA TGG CAC ATC GGA AAG AAT GAC AAG TATGTAATCC 799 Gly Asp Leu Lys Gly Trp His He Gly Lys Asn Asp Lys 200 205 TCATCCTAGC CTTTTATCAT TCAGTACAAC TTATTTGTTT TGTCTTGCAT ATACTTACTT 859 GTTTATTGAC TAACTTTCAA AT * "GCATATT AACATTCTAG GAAGATTTAA ATTGGACTCG 919 GGTCACAACT GAACCATATT ATTTTACACG ACAAAGCACG AGCTATTCCT AATGTAATTA 979 AAGTTAAAAT GCTCAATAAC GTGGAATATA TACTTGTATA CAGGGGCAAC AAACTATAAA 1039 TTGAAATATT ATTTCATATG AAGTTAACAT CTCAAAAATG TATTTAATAC TTGTAGG 1096 CAG GGA GCT ATA GCA GAC AAA GTA TCA GCA GAT ATA TGG TCA CAC ATA 1144 Gin Gly Ala He Ala Asp Lys Val Ser Ala Asp He Trp Ser His He 1 5 10 15 AGC AAG GAA AAT CTC ATT TTA GAA ACC GAT GAG TTG GTT GGA ATT GAT 1192 Ser Lys Glu Asn Leu He Leu Glu Thr Asp Glu Leu Val Gly He Asp 20 25 30 GAT CAC ATA ACA GCC GTA TTA GAA AAA TTG AGT TTA GAC TCT GAA AAT 1240 Asp His He Thr Ala Val Leu Glu Lys Leu Ser Leu Asp Ser Glu Asn 35 40 45 GTG ACA ATG GTC GGC CTT TAT GGT ATG GGT GGA ATA GGC AAG ACG ACC 1288 Val Thr Met Val Gly Leu Tyr Gly Met Gly Gly He Gly Lys Thr Thr 50 55 60 ACT GCA AAG GCG GTT TAT AAC AAG ATT TCT TCT TGT TTC GAT TGT TGT 1336 Thr Ala Lys Ala Val Tyr Asn Lys He Ser Ser Cys Phe Asp Cys Cys 65 70 75 80 TGT TTT ATT GAC AAC ATA CGT GAA ACA CAA GAG AAG GAT GGC GTT GTT 1384 Cys Phe He Asp Asn He Arg Glu Thr Gin Glu Lys Asp Gly Val Val 85 90 95 GTT TTG CAA AAG AAG CTA GTA TCT GAA ATT TTG AGG ATC GAT TCG GGT 1432 Val Leu Gin Lys Lys Leu Val Ser Glu He Leu Arg He Asp Ser Gly 100 105 110 TCG GTT GGA TTT AAT AAT GAT AGT GGC GGA CGG AAG ACG ATA AAG GAG 1480 Ser Val Gly Phe Asn Asn Asp Ser Gly Gly Arg Lys Thr He Lys Glu 115 120 125 AGA GTT TCG AGG TTC AAA ATT CTT GTC GTT CTC GAT GAT GTG GAT GAG 1528 Arg Val Ser Arg Phe Lys He Leu Val Val Leu Asp Asp Val Asp Glu 130 135 140 AAG TTT AAA TTT GAA GAT ATG TTG GGA AGT CCT AAA GAT TTT ATT TCT 1576 Lys Phe Lys Phe Glu Asp Met Leu Gly Ser Pro Lys Asp Phe He Ser 145 150 155 160 CAA AGT AGA TTC ATT ATT ACT TCA AGA AGT ATG AGA GTT TTG GGT ACT 1624 Gin Ser Arg Phe He He Thr Ser Arg Ser Met Arg Val Leu Gly Thr 165 170 175 TTG AAT GAG AAT CAA TGC AAG TTG TAT GAA GTT GGA TCG ATG AGC AAA 1672 Leu Asn Glu Asn Gin Cys Lys Leu Tyr Glu Val Gly Ser Met Ser Lys 180 185 190 CCA CGT TCG CTT GAA CTC TTC TCC AAG CAT GCA TTC AAA AAG AAT ACG 1720 Pro Arg Ser Leu Glu Leu Phe Ser Lys His Ala Phe Lys Lys Asn Thr 195 200 205 CCT CCA TCG TAT TAT GAG ACT CTA GCA AAT GAC GTC GTA GAT ACT ACA 1768 Pro Pro Ser Tyr Tyr Glu Thr Leu Ala Asn Asp Val Val Asp Thr Thr 210 215 220 GCA GGA CTT CCA TTG ACT CTG AAG GTT ATA GGA TCG CTT TTA TTT AAA 1816 Ala Gly Leu Pro Leu Thr Leu Lys Val He Gly Ser Leu Leu Phe Lys 225 230 235 240 CAA GAG ATT GCG GTT TGG GAA GAC ACG TTG GAA CAA TTA CGT AGA ACA 1864 Gin Glu He Ala Val Trp Glu Asp Thr Leu Glu Gin Leu Arg Arg Thr 245 250 255 CTT AAC CTT GAT GAG GTT TAT GAT AGG CTA AAA ATA AGT TAT GAT GCG 1912 Leu Asn Leu Asp Glu Val Tyr Asp Arg Leu Lys He Ser Tyr Asp Ala 260 265 270 TTG AAC CCG GAG GCA AAA GAG ATT TTC TTG GAT ATA GCT TGC TTC TTC 1960 Leu Asn Pro Glu Ala Lys Glu He Phe Leu Asp He Ala Cys Phe Phe 275 280 285 ATC GGA CAA AAT AAA GAA GAA CCG TAT TAC ATG TGG ACC GAC TGT AAT 2008 He Gly Gin Asn Lys Glu Glu Pro Tyr Tyr Met Trp Thr Asp Cys Asn 290 295 300 TTT TAT CCA GCA AGT AAT ATT ATT TTT CTC ATT CAA AGA TGT ATG ATA 2056 Phe Tyr Pro Ala Ser Asn He He Phe Leu He Gin Arg Cys Met He 305 310 315 320 CAA GTT GGG GAT GAT GAT GAG TTT AAA ATG CAC GAC CAA CTT AGA GAT 2104 Gin Val Gly Asp Asp Asp Glu Phe Lys Met His Asp Gin Leu Arg Asp 325 330 335 ATG GGT AGA GAA ATT GTG AGA CGA GAG GAT GTA CTG CCG TGG AAG AGA 2152 Met Gly Arg Glu He Val Arg Arg Glu Asp Val Leu Pro Trp Lys Arg 340 345 350 AGT AGA ATA TGG TCG GCA GAA GAA GGG ATT GAT CTC TTG CTG AAC AAA 2200 Ser Arg He Trp Ser Ala Glu Glu Gly He Asp Leu Leu Leu Asn Lys 355 360 365 AAG GTATTCAGTT TTATTTAAAA TTAAATATTC ATATATTATT ACACATACTT 2253 Lys TAAATCACAT AACTCATTAC GTTCCTTCTC CAATTACAG GGA TCA AGT AAA GTA 2307 Gly Ser Ser Lys Val 1 5 AAA GCA ATT AGC ATA CCC TGG GGT GTC AAG TAT GAG TTT AAG AGC GAA 2355 Lys Ala He Ser He Pro Trp Gly Val Lys Tyr Glu Phe Lys Ser Glu 10 15 20 TGT TTC TTG AAT TTG TCA GAG TTG AGA TAC CTC CAT GCA AGG GAA GCC 2403 Cys Phe Leu Asn Leu Ser Glu Leu Arg Tyr Leu His Ala Arg Glu Ala 25 30 35 ATG CTT ACC GGA GAT TTC AAC AAT CTT CTC CCG AAT TTA AAG TGG CTT 2451 Met Leu Thr Gly Asp Phe Asn Asn Leu Leu Pro Asn Leu Lys Trp Leu 40 45 50 GAG TTG CCA TTT TAC AAA CAT GGA GAG GAT GAT CCT CCT TTG ACC AAT 2 99 Glu Leu Pro Phe Tyr Lys His Gly Glu Asp Asp Pro Pro Leu Thr Asn 55 60 65 TAT ACC ATG AAA AAT CTG ATA ATT GTT ATT CTT GAG CAT AGC CAC ATA 2547 Tyr Thr Met Lys Asn Leu He He Val He Leu Glu His Ser His He 70 75 80 85 ACG GCT GAT GAT TGG GGA GGT TGG AGG CAT ATG ATG AAG GTGTGTTGTT 2596 Thr Ala Asp Asp Trp Gly Gly Trp Arg His Met Met Lys 90 95 TTTCAGCTGT TCATATGAAG GTGTGTTATC TTCTTATTTG TTCTTCATAT TTCTGTTTTA 2656 ATCTGCTGTC AG ATG GCT GAG AGG CTG AAA GTT GTA CGA CTT GCT TCA 2704 Met Ala Glu Arg Leu Lys Val Val Arg Leu Ala Ser 1 5 10 AAC TAT AGT TTG TAC GGA AGA CGT GTT CGC CTT TCT GAC TGT TGG CGC 2752 Asn Tyr Ser Leu Tyr Gly Arg Arg Val Arg Leu Ser Asp Cys Trp Arg 15 20 25 TTC CCC AAA AGC ATT GAG GTA TTA TCC ATG ACT GCG ATA GAA ATG GAT 2800 Phe Pro Lys Ser He Glu Val Leu Ser Met Thr Ala He Glu Met Asp 30 35 40 GAA GTT GAT ATT GGG GAG TTA AAG AAG CTA AAG ACG TTG GTT CTG AAA 2848 Glu Val Asp He Gly Glu Leu Lys Lys Leu Lys Thr Leu Val Leu Lys 45 50 55 60 TTC TGT CCA ATA CAA AAG ATA AGT GGG GGA ACC TTT GGT ATG TTG AAG 2896 Phe Cys Pro He Gin Lys He Ser Gly Gly Thr Phe Gly Met Leu Lys 65 70 75 GGA CTT CGA GAG CTT TGT CTC GAA TTC AAC TGG GGG ACA AAT TTG AGA 2944 Gly Leu Arg Glu Leu Cys Leu Glu Phe Asn Trp Gly Thr Asn Leu Arg 80 85 90 GAG GTA GTT GCC GAT ATT GGT CAA CTT TCA TCT CTC AAA GTC TTG AAA 2992 Glu Val Val Ala Asp He Gly Gin Leu Ser Ser Leu Lys Val Leu Lys 95 100 105 ACA ACC GGA GCT AAG GAG GTC GAG ATT AAT GAA TTT CCA TTA GGT TTG 3040 Thr Thr Gly Ala Lys Glu Val Glu He Asn Glu Phe Pro Leu Gly Leu 110 115 120 AAG GAG TTA TCC ACT TCA TCT CGG ATT CCG AAT CTT TCA CAG TTG TTG 3088 Lys Glu Leu Ser Thr Ser Ser Arg He Pro Asn Leu Ser Gin Leu Leu 125 130 135 140 GAT TTG GAG GTA CTG AAG GTT TAT GAT TGC AAG GAT GGA TTT GAC ATG 3136 Asp Leu Glu Val Leu Lys Val Tyr Asp Cys Lys Asp Gly Phe Asp Met 145 150 155 CCT" CCT GCT AGT CCG AGT GAA GAT GAA AGT AGT GTG TGG TGG AAG GTA 3184 Pro Pro Ala Ser Pro Ser Glu Asp Glu Ser Ser Val Trp Trp Lys Val 160 165 170 TCC AAG TTG AAG TCT TTG CAA CTC GAG AAG ACA AGA ATC AAT GTC AAC 3232 Ser Lys Leu Lys Ser Leu Gin Leu Glu Lys Thr Arg He Asn Val Asn 175 180 185 GTT GTG GAT GAT GCT TCT TCC GGT GGT CAC CTC CCT CGT TAC TTA CTA 3280 Val Val Asp Asp Ala Ser Ser Gly Gly His Leu Pro Arg Tyr Leu Leu 190 195 200 CCA ACA TCC CTA ACC TAT CTT AAA ATT TAT CAG TGT ACA GAA CCA ACG 3328 Pro Thr Ser Leu Thr Tyr Leu Lys He Tyr Gin Cys Thr Glu Pro Thr 205 210 215 220 TGG CTT CCA GGA ATA GAG AAC TTG GAG AAT TTG ACT TCG CTG GAA GTC 3376 Trp Leu Pro Gly He Glu Asn Leu Glu Asn Leu Thr Ser Leu Glu Val 225 230 235 AAC GAC ATC TTC CAA ACT CTT GGA GGT GAC TTG GAT GGG CTA CAA GGG 3424 Asn Asp He Phe Gin Thr Leu Gly Gly Asp Leu Asp Gly Leu Gin Gly 240 245 250 TTG AGA TCA TTG GAA ATT CTT AGG ATT CGG AAA GTA AAT GGT TTA GCT 3472 Leu Arg Ser Leu Glu He Leu Arg He Arg Lys Val Asn Gly Leu Ala 255 260 265 CGG ATC AAA GGG CTT AAG GAT CTC TTG TGT TCT TCT ACC TGC AAG TTG 3520 Arg He Lys Gly Leu Lys Asp Leu Leu Cys Ser Ser Thr Cys Lys Leu 270 275 280 CGG AAA TTT TAT ATT ACA GAA TGC CCC GAC CTC ATT GAG TTA CTC CCA 3568 Arg Lys Phe Tyr He Thr Glu Cys Pro Asp Leu He Glu Leu Leu Pro 285 290 295 300 TGC GAA CTC GGC GGC CAA ACA GTA GTA GTC CCC TCT ATG GCA GAA CTG 3616 Cys Glu Leu Gly Gly Gin Thr Val Val Val Pro Ser Met Ala Glu Leu 305 310 315 ACC ATT AGG GAT TGT CCA CGG CTG GAG GTT GGC CCG ATG ATA AGA TCA 3664 Thr He Arg Asp Cys Pro Arg Leu Glu Val Gly Pro Met He Arg Ser 320 325 330 CTC CCA AAG TTC CCA ATG CTA AAG AAG TTG GAC CTC GCG GTG GCA AAT 3712 Leu Pro Lys Phe Pro Met Leu Lys Lys Leu Asp Leu Ala Val Ala Asn 335 340 345 ATA ACT AAA GAG GAG GAT CTG GAT GCG ATT GGA TCC CTA GAA GAG TTG 3760 He Thr Lys Glu Glu Asp Leu Asp Ala He Gly Ser Leu Glu Glu Leu 350 355 360 GTT AGT TTG GAG TTA GAG TTA GAC GAT ACA TCT TCC GGT ATA GAG AGG 3808 Val Ser Leu Glu Leu Glu Leu Asp Asp Thr Ser Ser Gly He Glu Arg 365 370 375 380 ATA GTT TCC TCT TCG AAG CTG CAA AAG TTA ACT ACA CTC GTA GTG AAG 3856 He Val Ser Ser Ser Lys Leu Gin Lys Leu Thr Thr Leu Val Val Lys 385 390 395 GTG CCG AGT TTG CGG GAG ATT GAA GGG CTT GAA GAG TTG AAG TCT TTA 3904 Val Pro Ser Leu Arg Glu He Glu Gly Leu Glu Glu Leu Lys Ser Leu 400 405 410 CAA GAT TTG TAT CTA GAG GGT TGC ACG TCG TTG GGG AGA CTA CCA CTG 3952 Gin Asp Leu Tyr Leu Glu Gly Cys Thr Ser Leu Gly Arg Leu Pro Leu 415 420 425 GAG AAG CTG AAG GAG CTA GAC ATT GGA GGA TGC CCT GAC CTC ACT GAG 4000 Glu Lys Leu Lys Glu Leu Asp He Gly Gly Cys Pro Asp Leu Thr Glu 430 435 440 TTA GTC CAA ACA GTA GTA GCA GTC CCC TCT TTG AGA GGA CTG ACC ATT 4048 Leu Val Gin Thr Val Val Ala Val Pro Ser Leu Arg Gly Leu Thr He 445 450 455 460 AGG GAT TGT CCA CGG CTG GAG GTT GGT CCA ATG ATA CAA TCT CTT CCA 4096 Arg Asp Cys Pro Arg Leu Glu Val Gly Pro Met He Gin Ser Leu Pro 465 470 475 AAG TTC CCA ATG CTA AAT GAA TTG ACG CTC TCG ATG GTA AAT ATC ACT 4144 Lys Phe Pro Met Leu Asn Glu Leu Thr Leu Ser Met Val Asn He Thr 480 485 490 AAG GAG GAT GAG CTG GAG GTG CTT GGA TCC CTA GAA GAG TTG GAT AGT 4192 Lys Glu Asp Glu Leu Glu Val Leu Gly Ser Leu Glu Glu Leu Asp Ser 495 500 505 TTG GAG TTA ACG TTA GAC GAT ACA TGT TCC AGC ATA GAG AGG ATA TCT 4240 Leu Glu Leu Thr Leu Asp Asp Thr Cys Ser Ser He Glu Arg He Ser 510 515 520 TTC TTG TCG AAG CTG CAA AAG TTA ACT ACA CTC ATA GTG GAG GTG CCG 4288 Phe Leu Ser Lys Leu Gin Lys Leu Thr Thr Leu He Val Glu Val Pro 525 530 535 540 AGT TTG CGG GAG ATT GAA GGT CTT GCA GAG TTG AAG TCT TTA CGA ATT 4336 Ser Leu Arg Glu He Glu Gly Leu Ala Glu Leu Lys Ser Leu Arg He 545 550 555 TTG TAT CTA GAA GGA TGC ACG TCG TTG GAA AGA CTG TGG CCT GAT CAA 4384 Leu Tyr Leu Glu Gly Cys Thr Ser Leu Glu Arg Leu Trp Pro Asp Gin 560 565 570 CAA CAG TTG GGT AGT CTG AAG AAC CTG AAT GTG CTC GAC ATC CAA GGT 4432 Gin Gin Leu Gly Ser Leu Lys Asn Leu Asn Val Leu Asp He Gin Gly 575 580 585 TGT AAA AGC TTG AGT GTT GAC CAT CTC TCT GCA CTC AAG ACC ACT CTA 4480 Cys Lys Ser Leu Ser Val Asp His Leu Ser Ala Leu Lys Thr Thr Leu 590 595 600 CCG CCC AGG GCG AGG ATA ACA TGG CCC GAT CAG CCC TAC AGA TGACGGTAGG 4532 Pro Pro Arg Ala Arg He Thr Trp Pro Asp Gin Pro Tyr Arg 605 610 615 AATTAATGCA AGTGACAGTG ATGACATAGT TGTGATGGCT TGCACCTGAT CAACCTTGTT 4592 CTTCATGGGG TTTTCTCCCC AGTGAGATCT TAATATCCAA AATTCTGGTT TGTTCAGAGG 4652 TTATATGGTT CAGTTTTTCA CCATAATATT TTCTACGGCA TAGCGCAAAC TACTTCTAGT 4712 ATATAGATAT AGGCAATATA TATAACATCC AACTCTGTTT TACTCACTCC TCTCATCTTC 4772 TCACTCGATT ATGTTCCATT TCTAAAATCC ATTATTCATC GCCTTATATT CATAATTATG 4832 TAATTATTT 4841 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 208 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID Nθ:2: Met Ser Tyr Leu Arg Glu Val Ala Thr Ala Val Ala Leu Leu Leu Pro 1 5 10 15 Phe He Leu Leu Asn Lys Phe Trp Arg Pro Asn Ser Lys Asp Ser He 20 25 30 Val Asn Asp Asp Asp Asp Ser Thr Ser Glu Val Asp Ala He Ser Asp 35 40 45 Ser Thr Asn Pro Ser Gly Ser Phe Pro Ser Val Glu Tyr Glu Val Phe 50 55 . 60 Leu Ser Phe Arg Gly Pro Asp Thr Arg Glu Gin Phe Thr Asp Phe Leu 65 70 75 80 Tyr Gin Ser Leu Arg Arg Tyr Lys He His Thr Phe Arg Asp Asp Asp 85 90 95 Glu Leu Leu Lys Gly Lys Glu He Gly Pro Asn Leu Leu Arg Ala He 100 105 110 Asp Gin Ser Lys He Tyr Val Pro He He Ser Ser Gly Tyr Ala Asp 115 120 125 Ser Lys Trp Cys Leu Met Glu Leu Ala Glu He Val Arg Arg Gin Glu 130 135 140 Glu Asp Pro Arg Arg He He Leu Pro He Phe Tyr Met Val Asp Pro 145 150 155 160 Ser Asp Val Arg His Gin Thr Gly Cys Tyr Lys Lys Ala Phe Arg Lys 165 170 175 His Ala Asn Lys Phe Asp Gly Gin Thr He Gin Asn Trp Lys Asp Ala 180 185 190 Leu Lys Lys Val Gly Asp Leu Lys Gly Trp His He Gly Lys Asn Asp 195 200 205 Lys (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 369 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: Gin Gly Ala He Ala Asp Lys Val Ser Ala Asp He Trp Ser His He 1 5 10 15 Ser Lys Glu Asn Leu He Leu Glu Thr Asp Glu Leu Val Gly He Asp 20 25 30 Asp His He Thr Ala Val Leu Glu Lys Leu Ser Leu Asp Ser Glu Asn 35 40 45 Val Thr Met Val Gly Leu Tyr Gly Met Gly Gly He Gly Lys Thr Thr 50 55 60 Thr Ala Lys Ala Val Tyr Asn Lys He Ser Ser Cys Phe Asp Cys Cys 65 70 75 80 Cys Phe He Asp Asn He Arg Glu Thr Gin Glu Lys Asp Gly Val Val 85 90 95 Val Leu Gin Lys Lys Leu Val Ser Glu He Leu Arg He Asp Ser Gly 100 105 110 Ser Val Gly Phe Asn Asn Asp Ser Gly Gly Arg Lys Thr He Lys Glu 115 120 125 Arg Val Ser Arg Phe Lys He Leu Val Val Leu Asp Asp Val Asp Glu 130 135 140 Lys Phe Lys Phe Glu Asp Met Leu Gly Ser Pro Lys Asp Phe He Ser 145 150 155 160 Gin Ser Arg Phe He He Thr Ser Arg Ser Met Arg Val Leu Gly Thr 165 170 175 Leu Asn Glu Asn Gin Cys Lys Leu Tyr Glu Val Gly Ser Met Ser Lys 180 185 190 Pro Arg Ser Leu Glu Leu Phe Ser Lys His Ala Phe Lys Lys Asn Thr 195 200 205 Pro Pro Ser Tyr Tyr Glu Thr Leu Ala Asn Asp Val Val Asp Thr Thr 210 215 220 Ala Gly Leu Pro Leu Thr Leu Lys Val He Gly Ser Leu Leu Phe Lys 225 230 235 240 Gin Glu He Ala Val Trp Glu Asp Thr Leu Glu Gin Leu Arg Arg Thr 245 250 255 Leu Asn Leu Asp Glu Val Tyr Asp Arg Leu Lys He Ser Tyr Asp Ala 260 265 270 Leu Asn Pro Glu Ala Lys Glu He Phe Leu Asp He Ala Cys Phe Phe 275 280 285 He Gly Gin Asn Lys Glu Glu Pro Tyr Tyr Met Trp Thr Asp Cys Asn 290 295 300 Phe Tyr Pro Ala Ser Asn He He Phe Leu He Gin Arg Cys Met He 305 310 315 320 Gin Val Gly Asp Asp Asp Glu Phe Lys Met His Asp Gin Leu Arg Asp 325 330 335 Met Gly Arg Glu He Val Arg Arg Glu Asp Val Leu Pro Trp Lys Arg 340 345 350 Ser Arg He Trp Ser Ala Glu Glu Gly He Asp Leu Leu Leu Asn Lys 355 360 365 Lys (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 98 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: Gly Ser Ser Lys Val Lys Ala He Ser He Pro Trp Gly Val Lys Tyr 1 5 10 15 Glu Phe Lys Ser Glu Cys Phe Leu Asn Leu Ser Glu Leu Arg Tyr Leu 20 25 30 is Ala Arg Glu Ala Met Leu Thr Gly Asp Phe Asn Asn Leu Leu Pro 35 40 45 Asn Leu Lys Trp Leu Glu Leu Pro Phe Tyr Lys His Gly Glu Asp Asp 50 55 60 Pro Pro Leu Thr Asn Tyr Thr Met Lys Asn Leu He He Val He Leu 65 70 75 80 Glu His Ser His He Thr Ala Asp Asp Trp Gly Gly Trp Arg His Met 85 90 95 Met Lys (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 619 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: Met Ala Glu Arg Leu Lys Val Val Arg Leu Ala Ser Asn Tyr Ser Leu 1 5 10 15 Tyr Gly Arg Arg Val Arg Leu Ser Asp Cys Trp Arg Phe Pro Lys Ser 20 25 30 He Glu Val Leu Ser Met Thr Ala He Glu Met Asp Glu Val Asp He 35 40 45 Gly Glu Leu Lys Lys Leu Lys Thr Leu Val Leu Lys Phe Cys Pro He 50 55 60 Gin Lys He Ser Gly Gly Thr Phe Gly Met Leu Lys Gly Leu Arg Glu 65 70 75 80 Leu Cys Leu Glu Phe Asn Trp Gly Thr Asn Leu Arg Glu Val Val Ala 85 90 95 Asp He Gly Gin Leu Ser Ser Leu Lys Val Leu Lys Thr Thr Gly Ala 100 105 110 Lys Glu Val Glu He Asn Glu Phe Pro Leu Gly Leu Lys Glu Leu Ser 115 120 125 Thr Ser Ser Arg He Pro Asn Leu Ser Gin Leu Leu Asp Leu Glu Val 130 135 140 Leu Lys Val Tyr Asp Cys Lys Asp Gly Phe Asp Met Pro Pro Ala Ser 145 150 155 160 Pro Ser Glu Asp Glu Ser Ser Val Trp Trp Lys Val Ser Lys Leu Lys 165 170 175 Ser Leu Gin Leu Glu Lys Thr Arg He Asn Val Asn Val Val Asp Asp 180 185 190 Ala Ser Ser Gly Gly His Leu Pro Arg Tyr Leu Leu Pro Thr Ser Leu 195 200 205 Thr Tyr Leu Lys He Tyr Gin Cys Thr Glu Pro Thr Trp Leu Pro Gly 210 215 220 He Glu Asn Leu Glu Asn Leu Thr Ser Leu Glu Val Asn Asp He Phe 225 230 235 240 Gin Thr Leu Gly Gly Asp Leu Asp Gly Leu Gin Gly Leu Arg Ser Leu 245 250 255 Glu He Leu Arg He Arg Lys Val Asn Gly Leu Ala Arg He Lys Gly 260 265 270 Leu Lys Asp Leu Leu Cys Ser Ser Thr Cys Lys Leu Arg Lys Phe Tyr 275 280 285 He Thr Glu Cys Pro Asp Leu He Glu Leu Leu Pro Cys Glu Leu Gly 290 295 300 Gly Gin Thr Val Val Val Pro Ser Met Ala Glu Leu Thr He Arg Asp 305 310 315 320 Cys Pro Arg Leu Glu Val Gly Pro Met He Arg Ser Leu Pro Lys Phe 325 330 335 Pro Met Leu Lys Lys Leu Asp Leu Ala Val Ala Asn He Thr Lys Glu 340 345 350 Glu Asp Leu Asp Ala He Gly Ser Leu Glu Glu Leu Val Ser Leu Glu 355 360 365 Leu Glu Leu Asp Asp Thr Ser Ser Gly He Glu Arg He Val Ser Ser 370 375 380 Ser Lys Leu Gin Lys Leu Thr Thr Leu Val Val Lys Val Pro Ser Leu 385 390 395 400 Arg Glu He Glu Gly Leu Glu Glu Leu Lys Ser Leu Gin Asp Leu Tyr 405 410 .5 Leu Glu Gly Cys Thr Ser Leu Gly Arg Leu Pro Leu Glu Lys Leu Lys 420 425 430 Glu Leu Asp He Gly Gly Cys Pro Asp Leu Thr Glu Leu Val Gin Thr 435 440 445 Val Val Ala Val Pro Ser Leu Arg Gly Leu Thr He Arg Asp Cys Pro 450 455 460 Arg Leu Glu Val Gly Pro Met He Gin Ser Leu Pro Lys Phe Pro Met 465 470 475 480 Leu Asn Glu Leu Thr Leu Ser Met Val Asn He Thr Lys Glu Asp Glu 485 490 495 Leu Glu Val Leu Gly Ser Leu Glu Glu Leu Asp Ser Leu Glu Leu Thr 500 505 510 Leu Asp Asp Thr Cys Ser Ser He Glu Arg He Ser Phe Leu Ser Lys 515 520 525 Leu Gin Lys Leu Thr Thr Leu He Val Glu Val Pro Ser Leu Arg Glu 530 535 540 He Glu Gly Leu Ala Glu Leu Lys Ser Leu Arg He Leu Tyr Leu Glu 545 550 555 560 Gly Cys Thr Ser Leu Glu Arg Leu Trp Pro Asp Gin Gin Gin Leu Gly 565 570 575 Ser Leu Lys Asn Leu Asn Val Leu Asp He Gin Gly Cys Lys Ser Leu 580 585 590 Ser Val Asp His Leu Ser Ala Leu Lys Thr Thr Leu Pro Pro Arg Ala 595 600 605 Arg He Thr Trp Pro Asp Gin Pro Tyr Arg 610 615 (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 90 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..90 (xi) SEQUENCE DESCRIPTION*. SEQ ID NO:6: GTG TGT TGT TTT TCA GCT GTT CAT ATG AAG GTG TGT TAT CTT CTT ATT 48 Val Cys Cys Phe Ser Ala Val His Met Lys Val Cys Tyr Leu Leu He 1 5 10 15 TGT TCT TCA TAT TTC TGT TTT AAT CTG CTG TCA GAT GGC TG 90 Cys Ser Ser Tyr Phe Cys Phe Asn Leu Leu Ser Asp Gly 20 25 30 (2) INFORMATION FOR SEQ ID NO:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH*. 29 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: Val Cys Cys Phe Ser Ala Val His Met Lys Val Cys Tyr Leu Leu He 1 5 10 15 Cys Ser Ser Tyr Phe Cys Phe Asn Leu Leu Ser Asp Gly 20 25 (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: (xi(i)) /: Alternative amino acid Gly Xaa Xaa Xaa Xaa Gly Lys Thr / Ser 1 5 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 9 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: Gly Met Gly Gly He Gly Lys Thr Thr 1 5 (2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear ( ii ) MOLECULE TYPE : protein (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 10 : Gly Leu Tyr Gly Met Gly Gly He Gly Lys Thr Thr 1 5 10 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 840 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: AAAAAAAAAT TATAAGTTAA CAATTATACG TATGTTCCTA ACAATTGCTA AATAAATATT 60 ATCTCATCCT TCACTCCATT TTAGCAATTG TTAAAATTTT GGAATCGATA AATCTCGATC 120 CACTAACCAC TTCAAAATAG AAAAATAATG CGTAGCACAC AAACAACAGG ATTGGTGGCC 180 CCTTGATCAT GTAGCCAATT AGGTGATTCT TGTGGACAAG TAGAACTAGT TGTACTCGCT 240 AACCGGTCCG ATTTGAAATT TGACCCAGGT TTCGAAATTC TAACCAACCC AAATGGTTGA 300 CTGACTTGTG GGCCTGCATT ATTTGTAGAT AAGAAAGAGT TTACAAATGG TTGGCTTACA 360 TTGAATTTGT GGAGCAATAA TTGAGTTTTT GAATGGAGGA TACTGAAAGC CAGTGGGAGC 420 TCAGAAGTAA GGGATAAGGC AAGAAGCAGA GGAGCAGAGA GAAGAACCAG CAAAGCACAT 480 GCAAATTGAA GCAGGCAAGA ACAGTTACTG GAAATTCATT TATCTCTGCT TTCAATTTCT 540 ATCCTTCAGA TCATTTCTGC TCAATTGAAT CACTAGTCAT GAGTTATTTG AGAGAAGTTG 600 CTACTGCTGT TGCCTTGCTT CTCCCTTTCA TTCTTCTCAA CAAGTTTTGG AGACCAAATT 660 CCAAAGACTC AATCGTCAAC GATGATGACG ATTCAACATC TGAAGTTGAT GCCATATCCG 720 ACTCCACAAA TCCCTCTGGT TCATTTCCCT CCGTGGAGTA TGAAGTGTTT TTGAGTTTCA 780 GGGGTCCAGA TACTCGTGAA CAGTTCACCG ATTTCCTATA TCAGTCTCTC CGTCGCTATA 840 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 150 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: Pro Asp Leu Thr Glu Leu Val Gin Thr Val Val Ala Val Pro Ser Leu 1 5 10 15 Arg Gly Leu Thr He Arg Asp Cys Pro Arg Leu Glu Val Gly Pro Met 20 25 30 He Gin Ser Leu Pro Lys Phe Pro Met Leu Asn Glu Leu Thr Leu Ser 35 40 45 Met Val Asn He Thr Lys Glu Asp Glu Leu Glu Val Leu Gly Ser Leu 50 55 60 Glu Glu Leu Asp Ser Leu Glu Leu Thr Leu Asp Asp Thr Cys Ser Ser 65 70 75 80 He Glu Arg He Ser Phe Leu Ser Lys Leu Gin Lys Leu Thr Thr Leu 85 90 95 He Val Glu Val Pro Ser Leu Arg Glu He Glu Gly Leu Ala Glu Leu 100 105 110 Lys Ser Leu Arg He Leu Tyr Leu Glu Gly Cys Thr Ser Leu Glu Arg 115 120 125 Leu Trp Pro Asp Gin Gin Gin Leu Gly Ser Leu Lys Asn Leu Asn Val 130 135 140 Leu Asp He Gin Gly Cys 145 150 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 9 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: He Leu Val Val Leu Asp Asp Val Asp 1 5

Claims: CLAIMS 1. An isolated nucleic acid molecule comprising a sequence of nucleotides which confers or otherwise facilitates disease resistance in plants. 2. An isolated nucleic acid molecule according to claim 1 wherein the disease resistance is rust resistance. 3. An isolated nucleic aid molecule according to claim 2 comprising a sequence of nucleotides as set forth in SEQ ID NO:l or having at least 45% similarity to all or part thereof. 4. An isolated nucleic acid molecule according to claim 2 comprising a sequence of nucleotides encoding or complementary to a sequence of nucleotides encoding the amino acid sequence set forth in SEQ ID NOs:2 to 5 or having at least 45% similarity to all or part thereof. 5. An isolated nucleic acid molecule comprising a sequence of nucleotides encoding or complementary to a sequence encoding a peptide, polypeptide or protein which is capable of interacting with an avirulence gene product on a flax rust. 6. An isolated nucleic acid molecule according to claim 5 wherein the nucleic acid molecule corresponds to an allele of rust resistance gene L or M. 7. An isolated nucleic acid molecule according to claim 5 or 6 wherein the nucleic acid molecule corresponds to an L6 allele of rust resistance gene L and the corresponding avirulence gene is AL6. 8. An isolated nucleic acid molecule according to claim 5 or 6 wherein the nucleic acid molecule corresponds to the L2 allele of the rust resistance gene L and the corresponding avirulence gene is AL2. 9. An isolated nucleic acid molecule according to claim 5 or 6 wherein the nucleic acid molecule corresponds to the LIO allele of the rust resistance gene L and the corresponding avirulence gene is AL10. 10. An isolated nucleic acid molecule which: (i) confers rust resistance in a plant; and (ii) is capable of hybridizing under low stringency conditions to the nucleic acid molecule defined in SEQ ID NO:l. 11. An isolated nucleic acid molecule according to claim 10 wherein the nucleic acid molecule is capable of hybridizing to the nucleic acid defined in SEQ ID NOs:2 to 5 under medium stringent conditions. 12. An isolated nucleic acid molecule according to claim 10 wherein the nucleic acid molecule is capable to hybridizing to the nucleic acid defined in SEQ ID NO: 11 under high stringent conditions. 13. An isolated nucleic acid molecule according to claim 10 or 11 or 12 having a nucleotide sequence substantially corresponding to the nucleotide sequence set forth in SEQ ID NO:l or having at least 80% similarity to all or part thereof. 14. An isolated nucleic acid molecule according to claim 1 or 5 or 10 isolatable from a flax plant. 15. An isolated nucleic acid molecule according to claim 1 or 5 or 10 isolatable from a species of Linum or a soybean, sunflower, cereal, or wild varieties of wheat or barley. 16. An isolated nucleic acid molecule according to claim 15 isolatable from Linum marginale. 17. A method for identifying a rust resistance genetic sequence in a plant, said method comprising contacting genomic DNA or cDNA or mRNA from said plant with a hybridizing effective amount of a genetic sequence conferring or facilitating rust resistance or part thereof and then detecting said hybridization. 18. A method according to claim 17 wherein the plant is flax. 19. A method according to claim 17 wherein the plant is a species of Linum, soybean, sunflower, cereal, or a wild variety of wheat or barley. 20. A method according to claim 17 wherein the plant is Linum marginale. 21. A method according to claim 17 wherein the rust resistance genetic sequence is as set forth in SEQ ID NO:l or is a portion or part thereof encoding rust resistance or has at least 60% similarity thereto. 22. A method according to claim 17 wherein the rust resistance genetic sequence encodes an amino acid sequence substantially as set forth in SEQ ID NOs:2 to 5 or having at least 60% similarity thereto. 23. An isolated nucleic acid molecule comprising a sequence of nucleotides which: (i) confers or otherwise facilitates disease resistance in plants; and (ii) encodes a product having at least one leucine rich region and or comprises a p-loop at the 5' end of the nucleic acid molecule which encodes the amino acid sequence: GXXXXGKT/S, where X is any amino acid residue. 24. An isolated nucleic acid molecule according to claim 23 wherein the leucine rich region is a leucine rich repeat encoded by the 3' end of the molecule. 25. A nucleic acid molecule according to claim 23 or 24 wherein the leucine region comprises the amino acid sequence: PDLIE LPCE GGQTW . VPSMAELTIRDCPRLEVGPMIRSLPKFPMLKK LD AVANITKEEDLDAIGSLEELVSLELELDDTSSGIERIVSSSKLQKLT TLWKVPSLREIEGLEELKSLQDLYLEGCTSLGRL PLEKLKE LDIGGC or having at least 60% similarity to all or part thereof. 26. A nucleic acid molecule according to claim 23 wherein the p-loop sequence encodes the amino acid residues: GMGGIGKTT 27. A nucleic acid molecule according to claim 23 wherein the p-loop sequence encodes the amino acid residues: GLYGMGGIGKTT 28. A nucleic acid molecule according to claim 23 wherein the disease resistance is rust resistance. 29. A nucleic acid molecule according to claim 28 wherein the plant is a crop plant. 30. A nucleic acid molecule according to claim 29 wherein the plant is wheat or barley. 31. A nucleic acid molecule according to claim 23 comprising a nucleotide sequence as set forth in SEQ ID NO:l or encoding an amino acid sequence as set forth in SEQ ID NOs:2 to 5 or having at least 60% similarity to all or part thereof. 32. A modular resistance gene comprising heterologous genetic sequences from at least two nucleic acid molecules encoding disease resistance in plants. 33. A modular resistance gene according to claim 32 wherein the disease resistance is rust resistance. 34. A modular resistance gene according to claim 33 comprising all or part of genetic sequences encoding leucine rich regions from alleles of at least two rust resistance genes selected from L and M. 35. A modular resistance gene according to claim 34 comprising all or part of genetic sequences encoding leucine rich regions from alleles of at least two rust resistance genes selected from L6, L2 and LIO. 36. A transgenic plant carrying a non-indigenous genetic sequence conferring or otherwise facilitating rust resistance in said plant. 37. A transgenic plant according to claim 36 wherein the non-indigenous sequence comprises all or part of the nucleotide sequence set forth in SEQ ID NO:l or encodes an amino acid sequence as set forth in SEQ ID NOs:2 to 5 or having at least 60% similarity to all or part thereof. 38. A transgenic plant according to claim 36 or 37 wherein said plant is wheat or barley.

Inventors: ELLIS JEFFREY GRAHAM, FINNEGAN ELZABETH JEAN, LAWRENCE GREGORY JAMES, ELLIS, JEFFREY, GRAHAM, FINNEGAN, ELZABETH, JEAN, LAWRENCE, GREGORY, JAMES
Applicants: COMMW SCIENT IND RES ORG, ELLIS JEFFREY GRAHAM, FINNEGAN ELZABETH JEAN, LAWRENCE GREGORY JAMES, COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR, ELLIS, JEFFREY, GRAHAM, FINNEGAN, ELZABETH, JEAN, LAWRENCE, GREGORY, JAMES
Application year: 1995
Main classification: C12N15
IPC codes: C07K14, C12N15